Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial

INTRODUCTION: Treatment of latent tuberculosis infection (LTBI) plays a substantial role in the prevention of drug-susceptible tuberculosis (TB). However, clinical trials to evaluate the efficacy of preventive therapy for presumed multidrug-resistant (MDR) LTBI are lacking. This trial aims to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Greg J, Nguyen, Cam Binh, Nguyen, Thu Anh, Tran, Phuong Thuy, Marais, Ben J, Graham, Steve M, Nguyen, Binh Hoa, Velen, Kavi, Dowdy, David W, Mason, Paul, Britton, Warwick J, Behr, Marcel A, Benedetti, Andrea, Menzies, Dick, Nguyen, Viet Nhung, Marks, Guy B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955503/
https://www.ncbi.nlm.nih.gov/pubmed/31900274
http://dx.doi.org/10.1136/bmjopen-2019-033945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955503/
https://www.ncbi.nlm.nih.gov/pubmed/31900274
http://dx.doi.org/10.1136/bmjopen-2019-033945

Ejemplares similares